BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 7725808)

  • 1. [Antineutrophilic cytoplasmic antibodies (ANCA) in inflammatory rheumatic diseases: immunodiagnostic and immunopathogenetic aspects].
    Csernok E; Gross WL
    Z Rheumatol; 1995; 54(1):26-38. PubMed ID: 7725808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis.
    Gross WL; Csernok E
    Curr Opin Rheumatol; 1995 Jan; 7(1):11-9. PubMed ID: 7718417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineutrophil cytoplasmic autoantibody testing in vasculitides.
    Gross WL
    Rheum Dis Clin North Am; 1995 Nov; 21(4):987-1011. PubMed ID: 8592745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
    Malenica B; Rudolf M; Kozmar A
    Acta Dermatovenerol Croat; 2004; 12(4):294-313. PubMed ID: 15588565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANCA-associated vasculitis with renal involvement: an outcome analysis.
    Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
    Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
    Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
    J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neutrophil anticytoplasmic antibodies: their diagnostic utility in vasculitis and glomerulonephritis].
    Bosch X; Mirapeix E; Font J; López-Soto A; Rodríguez R; Vivancos J; Revert L; Ingelmo M; Urbano-Márquez A
    Med Clin (Barc); 1994 Mar; 102(11):412-7. PubMed ID: 8182997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA; Fass DN; Specks U
    Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
    Kallenberg CG; Heeringa P; Stegeman CA
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
    Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
    Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
    Reynolds WF; Stegeman CA; Tervaert JW
    Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis.
    Gross WL; Csernok E; Flesch BK
    J Autoimmun; 1993 Apr; 6(2):171-84. PubMed ID: 8388690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
    Csernok E; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New aspects of antineutrophil cytoplasmic antibody (ANCA) diagnosis in vasculitis].
    Csernok E; Reichel P; Gross WL
    Z Rheumatol; 2002 Aug; 61(4):367-77. PubMed ID: 12426842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ANCA-associated forms of vasculitis].
    Helmchen U; Kneissler U; Prall F
    Verh Dtsch Ges Pathol; 1996; 80():38-45. PubMed ID: 9065053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides.
    Csernok E; Schmitt WH; Ernst M; Bainton DF; Gross WL
    Adv Exp Med Biol; 1993; 336():45-50. PubMed ID: 8296655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective.
    Gross WL; Schmitt WH; Csernok E
    Am J Kidney Dis; 1991 Aug; 18(2):175-9. PubMed ID: 1867175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis.
    Gross WL; Csernok E; Helmchen U
    APMIS; 1995 Feb; 103(2):81-97. PubMed ID: 7748541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.